| GO:0005730 | nucleolus | 12.95% (25/193) | 5.22 | 0.0 | 0.0 |
| GO:0030684 | preribosome | 11.92% (23/193) | 5.6 | 0.0 | 0.0 |
| GO:0032040 | small-subunit processome | 9.84% (19/193) | 6.21 | 0.0 | 0.0 |
| GO:0003723 | RNA binding | 20.73% (40/193) | 3.23 | 0.0 | 0.0 |
| GO:1990904 | ribonucleoprotein complex | 15.03% (29/193) | 4.13 | 0.0 | 0.0 |
| GO:0032991 | protein-containing complex | 27.46% (53/193) | 2.57 | 0.0 | 0.0 |
| GO:0006139 | nucleobase-containing compound metabolic process | 26.42% (51/193) | 2.49 | 0.0 | 0.0 |
| GO:0006396 | RNA processing | 15.54% (30/193) | 3.69 | 0.0 | 0.0 |
| GO:0090304 | nucleic acid metabolic process | 24.35% (47/193) | 2.61 | 0.0 | 0.0 |
| GO:0016070 | RNA metabolic process | 19.69% (38/193) | 3.02 | 0.0 | 0.0 |
| GO:0003676 | nucleic acid binding | 30.05% (58/193) | 2.19 | 0.0 | 0.0 |
| GO:0046483 | heterocycle metabolic process | 26.42% (51/193) | 2.39 | 0.0 | 0.0 |
| GO:1901360 | organic cyclic compound metabolic process | 26.94% (52/193) | 2.35 | 0.0 | 0.0 |
| GO:0034641 | cellular nitrogen compound metabolic process | 26.94% (52/193) | 2.33 | 0.0 | 0.0 |
| GO:0006725 | cellular aromatic compound metabolic process | 26.42% (51/193) | 2.36 | 0.0 | 0.0 |
| GO:0005575 | cellular_component | 49.22% (95/193) | 1.3 | 0.0 | 0.0 |
| GO:0006364 | rRNA processing | 9.33% (18/193) | 4.58 | 0.0 | 0.0 |
| GO:0016072 | rRNA metabolic process | 9.33% (18/193) | 4.46 | 0.0 | 0.0 |
| GO:0031428 | box C/D RNP complex | 4.66% (9/193) | 7.46 | 0.0 | 0.0 |
| GO:0043228 | non-membrane-bounded organelle | 12.95% (25/193) | 3.37 | 0.0 | 0.0 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 12.95% (25/193) | 3.37 | 0.0 | 0.0 |
| GO:0005488 | binding | 50.26% (97/193) | 1.16 | 0.0 | 0.0 |
| GO:0005732 | sno(s)RNA-containing ribonucleoprotein complex | 4.66% (9/193) | 6.76 | 0.0 | 0.0 |
| GO:0097159 | organic cyclic compound binding | 37.82% (73/193) | 1.4 | 0.0 | 0.0 |
| GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.66% (9/193) | 6.39 | 0.0 | 0.0 |
| GO:0006807 | nitrogen compound metabolic process | 33.68% (65/193) | 1.48 | 0.0 | 0.0 |
| GO:0043170 | macromolecule metabolic process | 31.61% (61/193) | 1.54 | 0.0 | 0.0 |
| GO:0034470 | ncRNA processing | 9.33% (18/193) | 3.7 | 0.0 | 0.0 |
| GO:0034660 | ncRNA metabolic process | 10.36% (20/193) | 3.37 | 0.0 | 0.0 |
| GO:0043226 | organelle | 26.42% (51/193) | 1.7 | 0.0 | 0.0 |
| GO:0030515 | snoRNA binding | 4.66% (9/193) | 6.02 | 0.0 | 0.0 |
| GO:0043229 | intracellular organelle | 26.42% (51/193) | 1.7 | 0.0 | 0.0 |
| GO:0030490 | maturation of SSU-rRNA | 4.66% (9/193) | 5.97 | 0.0 | 0.0 |
| GO:0140513 | nuclear protein-containing complex | 11.4% (22/193) | 2.93 | 0.0 | 0.0 |
| GO:0003729 | mRNA binding | 7.77% (15/193) | 3.79 | 0.0 | 0.0 |
| GO:0003674 | molecular_function | 60.62% (117/193) | 0.78 | 0.0 | 0.0 |
| GO:0044238 | primary metabolic process | 34.2% (66/193) | 1.25 | 0.0 | 0.0 |
| GO:0044237 | cellular metabolic process | 30.05% (58/193) | 1.36 | 0.0 | 0.0 |
| GO:0071704 | organic substance metabolic process | 34.2% (66/193) | 1.16 | 0.0 | 0.0 |
| GO:0009987 | cellular process | 38.34% (74/193) | 1.06 | 0.0 | 0.0 |
| GO:0008150 | biological_process | 49.74% (96/193) | 0.84 | 0.0 | 0.0 |
| GO:0008152 | metabolic process | 34.72% (67/193) | 1.11 | 0.0 | 0.0 |
| GO:0004484 | mRNA guanylyltransferase activity | 2.07% (4/193) | 8.65 | 0.0 | 0.0 |
| GO:0004642 | phosphoribosylformylglycinamidine synthase activity | 1.55% (3/193) | 10.6 | 0.0 | 0.0 |
| GO:0006397 | mRNA processing | 5.18% (10/193) | 3.87 | 0.0 | 0.0 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 10.36% (20/193) | 2.36 | 0.0 | 0.0 |
| GO:0008192 | RNA guanylyltransferase activity | 2.07% (4/193) | 7.8 | 0.0 | 0.0 |
| GO:0006370 | 7-methylguanosine mRNA capping | 2.07% (4/193) | 7.23 | 0.0 | 0.0 |
| GO:0016071 | mRNA metabolic process | 5.7% (11/193) | 3.3 | 0.0 | 0.0 |
| GO:0009452 | 7-methylguanosine RNA capping | 2.07% (4/193) | 6.95 | 0.0 | 1e-06 |
| GO:0036260 | RNA capping | 2.07% (4/193) | 6.8 | 0.0 | 1e-06 |
| GO:0070568 | guanylyltransferase activity | 2.07% (4/193) | 6.7 | 0.0 | 1e-06 |
| GO:0043022 | ribosome binding | 3.11% (6/193) | 4.83 | 0.0 | 1e-06 |
| GO:0032545 | CURI complex | 1.55% (3/193) | 8.24 | 0.0 | 2e-06 |
| GO:0034456 | UTP-C complex | 1.55% (3/193) | 8.24 | 0.0 | 2e-06 |
| GO:0000049 | tRNA binding | 2.59% (5/193) | 5.36 | 0.0 | 2e-06 |
| GO:0043021 | ribonucleoprotein complex binding | 3.11% (6/193) | 4.45 | 0.0 | 6e-06 |
| GO:0032389 | MutLalpha complex | 1.55% (3/193) | 7.7 | 0.0 | 6e-06 |
| GO:0006409 | tRNA export from nucleus | 1.55% (3/193) | 7.63 | 1e-06 | 6e-06 |
| GO:0051031 | tRNA transport | 1.55% (3/193) | 7.63 | 1e-06 | 6e-06 |
| GO:0140098 | catalytic activity, acting on RNA | 6.74% (13/193) | 2.53 | 1e-06 | 7e-06 |
| GO:0097064 | ncRNA export from nucleus | 1.55% (3/193) | 7.33 | 1e-06 | 1.2e-05 |
| GO:0006188 | IMP biosynthetic process | 2.07% (4/193) | 5.78 | 1e-06 | 1.2e-05 |
| GO:0046040 | IMP metabolic process | 2.07% (4/193) | 5.68 | 1e-06 | 1.6e-05 |
| GO:1990116 | ribosome-associated ubiquitin-dependent protein catabolic process | 1.55% (3/193) | 7.14 | 1e-06 | 1.6e-05 |
| GO:1901990 | regulation of mitotic cell cycle phase transition | 2.59% (5/193) | 4.75 | 1e-06 | 1.7e-05 |
| GO:0030870 | Mre11 complex | 1.55% (3/193) | 7.12 | 2e-06 | 1.7e-05 |
| GO:0110165 | cellular anatomical entity | 31.61% (61/193) | 0.84 | 2e-06 | 2e-05 |
| GO:1990112 | RQC complex | 1.55% (3/193) | 7.0 | 2e-06 | 2.1e-05 |
| GO:0009126 | purine nucleoside monophosphate metabolic process | 2.07% (4/193) | 5.43 | 3e-06 | 2.7e-05 |
| GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2.07% (4/193) | 5.43 | 3e-06 | 2.7e-05 |
| GO:0009127 | purine nucleoside monophosphate biosynthetic process | 2.07% (4/193) | 5.44 | 3e-06 | 2.7e-05 |
| GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.07% (4/193) | 5.44 | 3e-06 | 2.7e-05 |
| GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 1.55% (3/193) | 6.83 | 3e-06 | 2.8e-05 |
| GO:0022613 | ribonucleoprotein complex biogenesis | 2.59% (5/193) | 4.58 | 3e-06 | 2.8e-05 |
| GO:0071840 | cellular component organization or biogenesis | 9.84% (19/193) | 1.74 | 5e-06 | 5.3e-05 |
| GO:0072344 | rescue of stalled ribosome | 1.55% (3/193) | 6.49 | 6e-06 | 5.5e-05 |
| GO:0009161 | ribonucleoside monophosphate metabolic process | 2.07% (4/193) | 5.14 | 6e-06 | 5.7e-05 |
| GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.07% (4/193) | 5.14 | 6e-06 | 5.7e-05 |
| GO:0000470 | maturation of LSU-rRNA | 2.07% (4/193) | 5.12 | 6e-06 | 5.8e-05 |
| GO:0009059 | macromolecule biosynthetic process | 6.22% (12/193) | 2.3 | 8e-06 | 6.9e-05 |
| GO:0034654 | nucleobase-containing compound biosynthetic process | 5.18% (10/193) | 2.6 | 8e-06 | 6.9e-05 |
| GO:0009123 | nucleoside monophosphate metabolic process | 2.07% (4/193) | 5.05 | 8e-06 | 6.9e-05 |
| GO:0007346 | regulation of mitotic cell cycle | 2.59% (5/193) | 4.26 | 8e-06 | 6.9e-05 |
| GO:0009124 | nucleoside monophosphate biosynthetic process | 2.07% (4/193) | 5.05 | 8e-06 | 6.9e-05 |
| GO:0030688 | preribosome, small subunit precursor | 1.55% (3/193) | 6.31 | 8e-06 | 7.3e-05 |
| GO:0043023 | ribosomal large subunit binding | 1.55% (3/193) | 6.26 | 9e-06 | 7.8e-05 |
| GO:0008419 | RNA lariat debranching enzyme activity | 1.04% (2/193) | 8.8 | 9e-06 | 7.9e-05 |
| GO:0044271 | cellular nitrogen compound biosynthetic process | 6.74% (13/193) | 2.15 | 1e-05 | 8.3e-05 |
| GO:0022411 | cellular component disassembly | 2.59% (5/193) | 4.11 | 1.3e-05 | 0.000103 |
| GO:0032300 | mismatch repair complex | 1.55% (3/193) | 6.11 | 1.3e-05 | 0.000104 |
| GO:1901987 | regulation of cell cycle phase transition | 2.59% (5/193) | 4.1 | 1.3e-05 | 0.000105 |
| GO:0006189 | 'de novo' IMP biosynthetic process | 1.55% (3/193) | 6.04 | 1.5e-05 | 0.000117 |
| GO:0006360 | transcription by RNA polymerase I | 1.55% (3/193) | 6.01 | 1.6e-05 | 0.000123 |
| GO:0032790 | ribosome disassembly | 1.55% (3/193) | 5.96 | 1.7e-05 | 0.000135 |
| GO:0030134 | COPII-coated ER to Golgi transport vesicle | 1.55% (3/193) | 5.89 | 2e-05 | 0.000153 |
| GO:0016779 | nucleotidyltransferase activity | 3.63% (7/193) | 3.11 | 2e-05 | 0.000154 |
| GO:0006281 | DNA repair | 4.66% (9/193) | 2.58 | 2.5e-05 | 0.000187 |
| GO:0061632 | RNA lariat debranching enzyme activator activity | 1.04% (2/193) | 8.08 | 2.6e-05 | 0.000192 |
| GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 1.55% (3/193) | 5.67 | 3.2e-05 | 0.000235 |
| GO:1902750 | negative regulation of cell cycle G2/M phase transition | 1.55% (3/193) | 5.63 | 3.5e-05 | 0.000247 |
| GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 1.55% (3/193) | 5.63 | 3.5e-05 | 0.000247 |
| GO:0044818 | mitotic G2/M transition checkpoint | 1.55% (3/193) | 5.63 | 3.5e-05 | 0.000247 |
| GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.55% (3/193) | 5.57 | 3.9e-05 | 0.000272 |
| GO:0097551 | mitochondrial double-strand break repair | 1.04% (2/193) | 7.7 | 4.4e-05 | 0.000308 |
| GO:0097552 | mitochondrial double-strand break repair via homologous recombination | 1.04% (2/193) | 7.7 | 4.4e-05 | 0.000308 |
| GO:1901362 | organic cyclic compound biosynthetic process | 5.7% (11/193) | 2.15 | 4.7e-05 | 0.000323 |
| GO:0006974 | DNA damage response | 4.66% (9/193) | 2.45 | 5.1e-05 | 0.000345 |
| GO:0051168 | nuclear export | 2.59% (5/193) | 3.68 | 5.1e-05 | 0.000346 |
| GO:0018130 | heterocycle biosynthetic process | 5.18% (10/193) | 2.24 | 6.5e-05 | 0.000433 |
| GO:0010564 | regulation of cell cycle process | 2.59% (5/193) | 3.6 | 6.7e-05 | 0.000445 |
| GO:0035494 | SNARE complex disassembly | 1.04% (2/193) | 7.39 | 6.8e-05 | 0.000446 |
| GO:0044773 | mitotic DNA damage checkpoint signaling | 1.55% (3/193) | 5.28 | 7.1e-05 | 0.000463 |
| GO:1902749 | regulation of cell cycle G2/M phase transition | 1.55% (3/193) | 5.26 | 7.4e-05 | 0.000472 |
| GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 1.55% (3/193) | 5.26 | 7.4e-05 | 0.000472 |
| GO:1901576 | organic substance biosynthetic process | 9.33% (18/193) | 1.51 | 7.6e-05 | 0.000482 |
| GO:0006259 | DNA metabolic process | 6.22% (12/193) | 1.95 | 8e-05 | 0.000505 |
| GO:0061951 | establishment of protein localization to plasma membrane | 1.04% (2/193) | 7.25 | 8.3e-05 | 0.000516 |
| GO:0043001 | Golgi to plasma membrane protein transport | 1.04% (2/193) | 7.25 | 8.3e-05 | 0.000516 |
| GO:0044249 | cellular biosynthetic process | 8.81% (17/193) | 1.55 | 8.8e-05 | 0.000539 |
| GO:0090150 | establishment of protein localization to membrane | 2.07% (4/193) | 4.12 | 9.5e-05 | 0.000576 |
| GO:0019438 | aromatic compound biosynthetic process | 5.18% (10/193) | 2.16 | 9.8e-05 | 0.000588 |
| GO:0044877 | protein-containing complex binding | 4.15% (8/193) | 2.5 | 0.000103 | 0.000617 |
| GO:0042254 | ribosome biogenesis | 1.55% (3/193) | 5.03 | 0.000118 | 0.000698 |
| GO:0006405 | RNA export from nucleus | 2.07% (4/193) | 3.98 | 0.000138 | 0.000811 |
| GO:0051236 | establishment of RNA localization | 2.07% (4/193) | 3.96 | 0.000143 | 0.000816 |
| GO:0050658 | RNA transport | 2.07% (4/193) | 3.96 | 0.000143 | 0.000816 |
| GO:0050657 | nucleic acid transport | 2.07% (4/193) | 3.96 | 0.000143 | 0.000816 |
| GO:0009058 | biosynthetic process | 9.33% (18/193) | 1.43 | 0.000144 | 0.000817 |
| GO:0033554 | cellular response to stress | 5.18% (10/193) | 2.1 | 0.000141 | 0.000822 |
| GO:0140664 | ATP-dependent DNA damage sensor activity | 1.55% (3/193) | 4.91 | 0.000149 | 0.000832 |
| GO:0140612 | DNA damage sensor activity | 1.55% (3/193) | 4.91 | 0.000149 | 0.000832 |
| GO:0000014 | single-stranded DNA endodeoxyribonuclease activity | 1.04% (2/193) | 6.82 | 0.000151 | 0.000834 |
| GO:0006298 | mismatch repair | 1.55% (3/193) | 4.89 | 0.000158 | 0.000867 |
| GO:0000027 | ribosomal large subunit assembly | 1.55% (3/193) | 4.88 | 0.000159 | 0.000868 |
| GO:0030135 | coated vesicle | 1.55% (3/193) | 4.85 | 0.000168 | 0.000911 |
| GO:1901989 | positive regulation of cell cycle phase transition | 1.04% (2/193) | 6.67 | 0.000185 | 0.000929 |
| GO:1901992 | positive regulation of mitotic cell cycle phase transition | 1.04% (2/193) | 6.67 | 0.000185 | 0.000929 |
| GO:1902101 | positive regulation of metaphase/anaphase transition of cell cycle | 1.04% (2/193) | 6.67 | 0.000185 | 0.000929 |
| GO:0005795 | Golgi stack | 1.04% (2/193) | 6.67 | 0.000185 | 0.000929 |
| GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 1.04% (2/193) | 6.67 | 0.000185 | 0.000929 |
| GO:0045840 | positive regulation of mitotic nuclear division | 1.04% (2/193) | 6.67 | 0.000185 | 0.000929 |
| GO:0045931 | positive regulation of mitotic cell cycle | 1.04% (2/193) | 6.67 | 0.000185 | 0.000929 |
| GO:1905820 | positive regulation of chromosome separation | 1.04% (2/193) | 6.67 | 0.000185 | 0.000929 |
| GO:1901970 | positive regulation of mitotic sister chromatid separation | 1.04% (2/193) | 6.67 | 0.000185 | 0.000929 |
| GO:0044774 | mitotic DNA integrity checkpoint signaling | 1.55% (3/193) | 4.84 | 0.000173 | 0.000929 |
| GO:0051716 | cellular response to stimulus | 5.18% (10/193) | 2.06 | 0.000177 | 0.000946 |
| GO:0051169 | nuclear transport | 2.59% (5/193) | 3.25 | 0.000203 | 0.001004 |
| GO:0006913 | nucleocytoplasmic transport | 2.59% (5/193) | 3.25 | 0.000203 | 0.001004 |
| GO:0009152 | purine ribonucleotide biosynthetic process | 2.07% (4/193) | 3.8 | 0.00022 | 0.001079 |
| GO:0034248 | regulation of amide metabolic process | 2.07% (4/193) | 3.79 | 0.000226 | 0.001092 |
| GO:0006417 | regulation of translation | 2.07% (4/193) | 3.79 | 0.000226 | 0.001092 |
| GO:0000077 | DNA damage checkpoint signaling | 1.55% (3/193) | 4.63 | 0.000264 | 0.001264 |
| GO:0042770 | signal transduction in response to DNA damage | 1.55% (3/193) | 4.63 | 0.000264 | 0.001264 |
| GO:0006414 | translational elongation | 1.55% (3/193) | 4.63 | 0.000267 | 0.001266 |
| GO:0072657 | protein localization to membrane | 2.07% (4/193) | 3.71 | 0.000278 | 0.00131 |
| GO:0051641 | cellular localization | 5.18% (10/193) | 1.97 | 0.000289 | 0.001353 |
| GO:1903008 | organelle disassembly | 1.55% (3/193) | 4.57 | 0.000296 | 0.001381 |
| GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 2.59% (5/193) | 3.13 | 0.000303 | 0.001403 |
| GO:0006428 | isoleucyl-tRNA aminoacylation | 1.04% (2/193) | 6.23 | 0.000343 | 0.00156 |
| GO:0004822 | isoleucine-tRNA ligase activity | 1.04% (2/193) | 6.23 | 0.000343 | 0.00156 |
| GO:0140299 | small molecule sensor activity | 1.55% (3/193) | 4.51 | 0.00034 | 0.001565 |
| GO:0051726 | regulation of cell cycle | 2.59% (5/193) | 3.07 | 0.000361 | 0.00163 |
| GO:0044085 | cellular component biogenesis | 2.59% (5/193) | 3.06 | 0.000375 | 0.001685 |
| GO:0071705 | nitrogen compound transport | 4.66% (9/193) | 2.05 | 0.000382 | 0.001702 |
| GO:1902494 | catalytic complex | 5.7% (11/193) | 1.8 | 0.000391 | 0.001732 |
| GO:0000439 | transcription factor TFIIH core complex | 1.04% (2/193) | 6.13 | 0.000395 | 0.001739 |
| GO:0072659 | protein localization to plasma membrane | 1.04% (2/193) | 6.11 | 0.000403 | 0.001767 |
| GO:1990778 | protein localization to cell periphery | 1.04% (2/193) | 6.1 | 0.000412 | 0.001796 |
| GO:1901991 | negative regulation of mitotic cell cycle phase transition | 1.55% (3/193) | 4.38 | 0.000437 | 0.001892 |
| GO:0006289 | nucleotide-excision repair | 1.55% (3/193) | 4.38 | 0.00044 | 0.001893 |
| GO:0006351 | DNA-templated transcription | 2.59% (5/193) | 3.0 | 0.000448 | 0.001915 |
| GO:0010498 | proteasomal protein catabolic process | 2.59% (5/193) | 2.99 | 0.000467 | 0.001985 |
| GO:0043231 | intracellular membrane-bounded organelle | 13.99% (27/193) | 1.0 | 0.000489 | 0.002067 |
| GO:1990234 | transferase complex | 4.15% (8/193) | 2.16 | 0.000495 | 0.002083 |
| GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 1.04% (2/193) | 5.93 | 0.000517 | 0.002164 |
| GO:0016462 | pyrophosphatase activity | 4.66% (9/193) | 1.98 | 0.000538 | 0.002237 |
| GO:0031570 | DNA integrity checkpoint signaling | 1.55% (3/193) | 4.27 | 0.000543 | 0.002247 |
| GO:0043227 | membrane-bounded organelle | 13.99% (27/193) | 0.99 | 0.000548 | 0.002253 |
| GO:0006164 | purine nucleotide biosynthetic process | 2.07% (4/193) | 3.43 | 0.000568 | 0.002324 |
| GO:0019843 | rRNA binding | 1.55% (3/193) | 4.23 | 0.00059 | 0.0024 |
| GO:0005786 | signal recognition particle, endoplasmic reticulum targeting | 1.04% (2/193) | 5.82 | 0.000601 | 0.002418 |
| GO:0022618 | protein-RNA complex assembly | 2.07% (4/193) | 3.41 | 0.0006 | 0.002427 |
| GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.66% (9/193) | 1.96 | 0.000607 | 0.002427 |
| GO:0000398 | mRNA splicing, via spliceosome | 2.07% (4/193) | 3.39 | 0.000629 | 0.002503 |
| GO:0016817 | hydrolase activity, acting on acid anhydrides | 4.66% (9/193) | 1.94 | 0.000649 | 0.002568 |
| GO:0071826 | protein-RNA complex organization | 2.07% (4/193) | 3.37 | 0.000672 | 0.002643 |
| GO:0030163 | protein catabolic process | 2.59% (5/193) | 2.87 | 0.000685 | 0.00268 |
| GO:0016043 | cellular component organization | 7.25% (14/193) | 1.46 | 0.000694 | 0.00269 |
| GO:0071014 | post-mRNA release spliceosomal complex | 1.04% (2/193) | 5.72 | 0.000691 | 0.002692 |
| GO:0015931 | nucleobase-containing compound transport | 2.07% (4/193) | 3.34 | 0.000722 | 0.002783 |
| GO:0009260 | ribonucleotide biosynthetic process | 2.07% (4/193) | 3.33 | 0.000738 | 0.002828 |
| GO:0007093 | mitotic cell cycle checkpoint signaling | 1.55% (3/193) | 4.12 | 0.000742 | 0.002829 |
| GO:0016887 | ATP hydrolysis activity | 3.63% (7/193) | 2.26 | 0.000756 | 0.002855 |
| GO:0008312 | 7S RNA binding | 1.04% (2/193) | 5.65 | 0.000763 | 0.002864 |
| GO:0072522 | purine-containing compound biosynthetic process | 2.07% (4/193) | 3.32 | 0.000755 | 0.002866 |
| GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.07% (4/193) | 3.31 | 0.000769 | 0.002873 |
| GO:0070979 | protein K11-linked ubiquitination | 1.04% (2/193) | 5.63 | 0.000787 | 0.002926 |
| GO:0005675 | transcription factor TFIIH holo complex | 1.04% (2/193) | 5.62 | 0.0008 | 0.002957 |
| GO:0046390 | ribose phosphate biosynthetic process | 2.07% (4/193) | 3.28 | 0.000839 | 0.003088 |
| GO:0007389 | pattern specification process | 1.04% (2/193) | 5.57 | 0.00085 | 0.003113 |
| GO:0051668 | localization within membrane | 2.07% (4/193) | 3.27 | 0.000861 | 0.003137 |
| GO:0140097 | catalytic activity, acting on DNA | 3.63% (7/193) | 2.22 | 0.000875 | 0.003173 |
| GO:0051785 | positive regulation of nuclear division | 1.04% (2/193) | 5.52 | 0.000916 | 0.003304 |
| GO:0000375 | RNA splicing, via transesterification reactions | 2.07% (4/193) | 3.2 | 0.001029 | 0.003693 |
| GO:0045930 | negative regulation of mitotic cell cycle | 1.55% (3/193) | 3.92 | 0.001089 | 0.003891 |
| GO:0048500 | signal recognition particle | 1.04% (2/193) | 5.33 | 0.001186 | 0.004216 |
| GO:0032543 | mitochondrial translation | 1.04% (2/193) | 5.24 | 0.001341 | 0.004746 |
| GO:0035861 | site of double-strand break | 1.04% (2/193) | 5.21 | 0.00139 | 0.004871 |
| GO:0090734 | site of DNA damage | 1.04% (2/193) | 5.21 | 0.00139 | 0.004871 |
| GO:0090068 | positive regulation of cell cycle process | 1.04% (2/193) | 5.19 | 0.001439 | 0.004996 |
| GO:0045787 | positive regulation of cell cycle | 1.04% (2/193) | 5.19 | 0.001439 | 0.004996 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 10.88% (21/193) | 1.04 | 0.001476 | 0.005102 |
| GO:0017111 | ribonucleoside triphosphate phosphatase activity | 4.15% (8/193) | 1.91 | 0.001492 | 0.005132 |
| GO:0051603 | proteolysis involved in protein catabolic process | 3.11% (6/193) | 2.29 | 0.001566 | 0.005361 |
| GO:0000075 | cell cycle checkpoint signaling | 1.55% (3/193) | 3.72 | 0.001633 | 0.005565 |
| GO:0071702 | organic substance transport | 4.66% (9/193) | 1.72 | 0.001845 | 0.006229 |
| GO:0008380 | RNA splicing | 2.07% (4/193) | 2.97 | 0.001841 | 0.006244 |
| GO:0043933 | protein-containing complex organization | 3.63% (7/193) | 2.01 | 0.001999 | 0.006717 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 2.59% (5/193) | 2.51 | 0.002022 | 0.006766 |
| GO:1901137 | carbohydrate derivative biosynthetic process | 2.59% (5/193) | 2.5 | 0.002077 | 0.006917 |
| GO:1901988 | negative regulation of cell cycle phase transition | 1.55% (3/193) | 3.59 | 0.002101 | 0.006934 |
| GO:0010948 | negative regulation of cell cycle process | 1.55% (3/193) | 3.59 | 0.002101 | 0.006934 |
| GO:0032774 | RNA biosynthetic process | 2.59% (5/193) | 2.49 | 0.002139 | 0.00703 |
| GO:0042138 | meiotic DNA double-strand break formation | 1.04% (2/193) | 4.88 | 0.002175 | 0.007115 |
| GO:1904161 | DNA synthesis involved in UV-damage excision repair | 0.52% (1/193) | 8.8 | 0.002246 | 0.007314 |
| GO:0010638 | positive regulation of organelle organization | 1.04% (2/193) | 4.84 | 0.002298 | 0.007451 |
| GO:0009165 | nucleotide biosynthetic process | 2.07% (4/193) | 2.88 | 0.002327 | 0.007479 |
| GO:1901293 | nucleoside phosphate biosynthetic process | 2.07% (4/193) | 2.88 | 0.002327 | 0.007479 |
| GO:0031145 | anaphase-promoting complex-dependent catabolic process | 1.04% (2/193) | 4.77 | 0.002532 | 0.007997 |
| GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.04% (2/193) | 4.77 | 0.002532 | 0.007997 |
| GO:0006613 | cotranslational protein targeting to membrane | 1.04% (2/193) | 4.77 | 0.002532 | 0.007997 |
| GO:0061578 | K63-linked deubiquitinase activity | 0.52% (1/193) | 8.6 | 0.002566 | 0.008038 |
| GO:0140492 | metal-dependent deubiquitinase activity | 0.52% (1/193) | 8.6 | 0.002566 | 0.008038 |
| GO:0045786 | negative regulation of cell cycle | 1.55% (3/193) | 3.5 | 0.002531 | 0.0081 |
| GO:0010608 | post-transcriptional regulation of gene expression | 2.07% (4/193) | 2.82 | 0.002646 | 0.008251 |
| GO:0032806 | carboxy-terminal domain protein kinase complex | 1.04% (2/193) | 4.72 | 0.002708 | 0.00841 |
| GO:0140818 | mRNA 5'-phosphatase activity | 0.52% (1/193) | 8.43 | 0.002887 | 0.008927 |
| GO:0006366 | transcription by RNA polymerase II | 1.04% (2/193) | 4.64 | 0.003007 | 0.009261 |
| GO:0019941 | modification-dependent protein catabolic process | 2.59% (5/193) | 2.37 | 0.003034 | 0.009303 |
| GO:0005680 | anaphase-promoting complex | 1.04% (2/193) | 4.59 | 0.003223 | 0.009643 |
| GO:1905818 | regulation of chromosome separation | 1.04% (2/193) | 4.59 | 0.003223 | 0.009643 |
| GO:0010965 | regulation of mitotic sister chromatid separation | 1.04% (2/193) | 4.59 | 0.003223 | 0.009643 |
| GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.04% (2/193) | 4.59 | 0.003223 | 0.009643 |
| GO:0007088 | regulation of mitotic nuclear division | 1.04% (2/193) | 4.59 | 0.003223 | 0.009643 |
| GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 1.04% (2/193) | 4.59 | 0.003223 | 0.009643 |
| GO:0070816 | obsolete phosphorylation of RNA polymerase II C-terminal domain | 1.04% (2/193) | 4.59 | 0.003247 | 0.009676 |
| GO:0006893 | Golgi to plasma membrane transport | 1.04% (2/193) | 4.58 | 0.003296 | 0.009783 |
| GO:0006303 | double-strand break repair via nonhomologous end joining | 1.04% (2/193) | 4.55 | 0.003396 | 0.010037 |
| GO:0043632 | modification-dependent macromolecule catabolic process | 2.59% (5/193) | 2.31 | 0.003613 | 0.010637 |
| GO:0051130 | positive regulation of cellular component organization | 1.04% (2/193) | 4.46 | 0.003859 | 0.011315 |
| GO:0097708 | intracellular vesicle | 2.07% (4/193) | 2.64 | 0.004131 | 0.012018 |
| GO:0031410 | cytoplasmic vesicle | 2.07% (4/193) | 2.64 | 0.004131 | 0.012018 |
| GO:0065003 | protein-containing complex assembly | 2.59% (5/193) | 2.26 | 0.00423 | 0.012256 |
| GO:0031461 | cullin-RING ubiquitin ligase complex | 1.55% (3/193) | 3.19 | 0.004539 | 0.013102 |
| GO:0004520 | DNA endonuclease activity | 1.04% (2/193) | 4.33 | 0.004605 | 0.01324 |
| GO:0006605 | protein targeting | 1.55% (3/193) | 3.15 | 0.004904 | 0.014046 |
| GO:0000152 | nuclear ubiquitin ligase complex | 1.04% (2/193) | 4.28 | 0.004927 | 0.014056 |
| GO:0072599 | establishment of protein localization to endoplasmic reticulum | 1.04% (2/193) | 4.21 | 0.005382 | 0.015177 |
| GO:0045047 | protein targeting to ER | 1.04% (2/193) | 4.21 | 0.005382 | 0.015177 |
| GO:0033045 | regulation of sister chromatid segregation | 1.04% (2/193) | 4.21 | 0.005382 | 0.015177 |
| GO:0004519 | endonuclease activity | 2.07% (4/193) | 2.51 | 0.005656 | 0.015888 |
| GO:0005634 | nucleus | 7.77% (15/193) | 1.07 | 0.005746 | 0.016081 |
| GO:0051246 | regulation of protein metabolic process | 2.07% (4/193) | 2.49 | 0.005957 | 0.016609 |
| GO:0051783 | regulation of nuclear division | 1.04% (2/193) | 4.12 | 0.00605 | 0.01674 |
| GO:0061695 | transferase complex, transferring phosphorus-containing groups | 2.07% (4/193) | 2.48 | 0.006079 | 0.016757 |
| GO:0045184 | establishment of protein localization | 3.11% (6/193) | 1.89 | 0.00604 | 0.016776 |
| GO:0051983 | regulation of chromosome segregation | 1.04% (2/193) | 4.1 | 0.006215 | 0.017067 |
| GO:0000724 | double-strand break repair via homologous recombination | 1.55% (3/193) | 3.02 | 0.006296 | 0.017227 |
| GO:0097367 | carbohydrate derivative binding | 11.92% (23/193) | 0.81 | 0.006337 | 0.017275 |
| GO:0009150 | purine ribonucleotide metabolic process | 2.07% (4/193) | 2.46 | 0.006464 | 0.017555 |
| GO:0098876 | vesicle-mediated transport to the plasma membrane | 1.04% (2/193) | 4.04 | 0.006789 | 0.018369 |
| GO:0090407 | organophosphate biosynthetic process | 2.59% (5/193) | 2.09 | 0.006912 | 0.018634 |
| GO:0000725 | recombinational repair | 1.55% (3/193) | 2.95 | 0.007233 | 0.01943 |
| GO:0005524 | ATP binding | 9.33% (18/193) | 0.92 | 0.007469 | 0.019989 |
| GO:0070972 | protein localization to endoplasmic reticulum | 1.04% (2/193) | 3.96 | 0.007566 | 0.020175 |
| GO:0031982 | vesicle | 2.07% (4/193) | 2.38 | 0.007714 | 0.020495 |
| GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 1.55% (3/193) | 2.88 | 0.008161 | 0.021606 |
| GO:0140535 | intracellular protein-containing complex | 3.11% (6/193) | 1.8 | 0.008289 | 0.021866 |
| GO:0009057 | macromolecule catabolic process | 3.11% (6/193) | 1.78 | 0.008649 | 0.022734 |
| GO:0008094 | ATP-dependent activity, acting on DNA | 2.07% (4/193) | 2.33 | 0.008749 | 0.022833 |
| GO:0030686 | 90S preribosome | 1.04% (2/193) | 3.85 | 0.008725 | 0.022854 |
| GO:0006260 | DNA replication | 1.55% (3/193) | 2.83 | 0.009081 | 0.023617 |
| GO:0061982 | meiosis I cell cycle process | 1.04% (2/193) | 3.8 | 0.009313 | 0.023967 |
| GO:0050794 | regulation of cellular process | 9.33% (18/193) | 0.89 | 0.009251 | 0.023973 |
| GO:0016874 | ligase activity | 2.59% (5/193) | 1.98 | 0.009298 | 0.024012 |
| GO:0006892 | post-Golgi vesicle-mediated transport | 1.04% (2/193) | 3.79 | 0.009393 | 0.024088 |
| GO:0071339 | MLL1 complex | 0.52% (1/193) | 6.7 | 0.009591 | 0.024257 |
| GO:0044665 | MLL1/2 complex | 0.52% (1/193) | 6.7 | 0.009591 | 0.024257 |
| GO:0051267 | CP2 mannose-ethanolamine phosphotransferase activity | 0.52% (1/193) | 6.7 | 0.009591 | 0.024257 |
| GO:0002151 | G-quadruplex RNA binding | 0.52% (1/193) | 6.7 | 0.009591 | 0.024257 |
| GO:0046907 | intracellular transport | 3.11% (6/193) | 1.74 | 0.009829 | 0.024774 |
| GO:0008104 | protein localization | 3.11% (6/193) | 1.74 | 0.009982 | 0.025074 |
| GO:0070727 | cellular macromolecule localization | 3.11% (6/193) | 1.73 | 0.010087 | 0.025253 |
| GO:0033036 | macromolecule localization | 3.11% (6/193) | 1.73 | 0.010178 | 0.025392 |
| GO:0016787 | hydrolase activity | 9.84% (19/193) | 0.84 | 0.010214 | 0.025396 |
| GO:0032555 | purine ribonucleotide binding | 11.4% (22/193) | 0.77 | 0.010344 | 0.025633 |
| GO:0009259 | ribonucleotide metabolic process | 2.07% (4/193) | 2.25 | 0.010438 | 0.025779 |
| GO:0006612 | protein targeting to membrane | 1.04% (2/193) | 3.71 | 0.010498 | 0.025842 |
| GO:1901566 | organonitrogen compound biosynthetic process | 3.63% (7/193) | 1.55 | 0.010987 | 0.026954 |
| GO:0005743 | mitochondrial inner membrane | 1.04% (2/193) | 3.66 | 0.011136 | 0.02723 |
| GO:0032553 | ribonucleotide binding | 11.4% (22/193) | 0.76 | 0.011294 | 0.027524 |
| GO:0051649 | establishment of localization in cell | 3.11% (6/193) | 1.69 | 0.011464 | 0.027846 |
| GO:0019693 | ribose phosphate metabolic process | 2.07% (4/193) | 2.19 | 0.011969 | 0.028979 |
| GO:0044545 | NSL complex | 0.52% (1/193) | 6.36 | 0.012132 | 0.029277 |
| GO:0005783 | endoplasmic reticulum | 2.07% (4/193) | 2.16 | 0.012886 | 0.030994 |
| GO:0032984 | protein-containing complex disassembly | 1.04% (2/193) | 3.54 | 0.013149 | 0.03142 |
| GO:0051276 | chromosome organization | 2.07% (4/193) | 2.15 | 0.013134 | 0.031487 |
| GO:0033044 | regulation of chromosome organization | 1.04% (2/193) | 3.5 | 0.013805 | 0.032882 |
| GO:0030691 | Noc2p-Noc3p complex | 0.52% (1/193) | 6.11 | 0.014351 | 0.033639 |
| GO:0030690 | Noc1p-Noc2p complex | 0.52% (1/193) | 6.11 | 0.014351 | 0.033639 |
| GO:0036387 | pre-replicative complex | 0.52% (1/193) | 6.11 | 0.014351 | 0.033639 |
| GO:0005656 | nuclear pre-replicative complex | 0.52% (1/193) | 6.11 | 0.014351 | 0.033639 |
| GO:0006875 | obsolete intracellular metal ion homeostasis | 0.52% (1/193) | 6.11 | 0.014351 | 0.033639 |
| GO:0050789 | regulation of biological process | 9.33% (18/193) | 0.82 | 0.014679 | 0.033975 |
| GO:0003690 | double-stranded DNA binding | 2.59% (5/193) | 1.82 | 0.014571 | 0.034045 |
| GO:0035672 | oligopeptide transmembrane transport | 0.52% (1/193) | 6.08 | 0.014668 | 0.034056 |
| GO:0090374 | oligopeptide export from mitochondrion | 0.52% (1/193) | 6.08 | 0.014668 | 0.034056 |
| GO:0000151 | ubiquitin ligase complex | 1.55% (3/193) | 2.54 | 0.015412 | 0.035559 |
| GO:0017076 | purine nucleotide binding | 11.4% (22/193) | 0.71 | 0.015516 | 0.035686 |
| GO:0043625 | delta DNA polymerase complex | 0.52% (1/193) | 5.99 | 0.015617 | 0.035696 |
| GO:0006163 | purine nucleotide metabolic process | 2.07% (4/193) | 2.08 | 0.015587 | 0.035738 |
| GO:0000120 | RNA polymerase I transcription regulator complex | 0.52% (1/193) | 5.96 | 0.015933 | 0.036306 |
| GO:0005667 | transcription regulator complex | 1.55% (3/193) | 2.51 | 0.016363 | 0.03717 |
| GO:0009772 | photosynthetic electron transport in photosystem II | 0.52% (1/193) | 5.88 | 0.016881 | 0.03823 |
| GO:1901565 | organonitrogen compound catabolic process | 2.59% (5/193) | 1.75 | 0.017319 | 0.038981 |
| GO:0019866 | organelle inner membrane | 1.04% (2/193) | 3.33 | 0.017292 | 0.039038 |
| GO:0042023 | DNA endoreduplication | 0.52% (1/193) | 5.8 | 0.017828 | 0.040005 |
| GO:0006891 | intra-Golgi vesicle-mediated transport | 1.04% (2/193) | 3.3 | 0.018029 | 0.040333 |
| GO:1901363 | heterocyclic compound binding | 11.92% (23/193) | 0.67 | 0.018124 | 0.040421 |
| GO:0005515 | protein binding | 11.92% (23/193) | 0.67 | 0.018654 | 0.041478 |
| GO:0047623 | adenosine-phosphate deaminase activity | 0.52% (1/193) | 5.72 | 0.018774 | 0.041495 |
| GO:0003876 | AMP deaminase activity | 0.52% (1/193) | 5.72 | 0.018774 | 0.041495 |
| GO:0072521 | purine-containing compound metabolic process | 2.07% (4/193) | 1.99 | 0.019088 | 0.042063 |
| GO:0006302 | double-strand break repair | 1.55% (3/193) | 2.42 | 0.019294 | 0.042389 |
| GO:0036094 | small molecule binding | 11.92% (23/193) | 0.66 | 0.019436 | 0.042574 |
| GO:0019684 | photosynthesis, light reaction | 0.52% (1/193) | 5.63 | 0.020035 | 0.043755 |
| GO:0140657 | ATP-dependent activity | 4.15% (8/193) | 1.26 | 0.020302 | 0.044208 |
| GO:0006996 | organelle organization | 3.63% (7/193) | 1.36 | 0.020669 | 0.044351 |
| GO:0032264 | IMP salvage | 0.52% (1/193) | 5.56 | 0.020979 | 0.044368 |
| GO:0106380 | purine ribonucleotide salvage | 0.52% (1/193) | 5.56 | 0.020979 | 0.044368 |
| GO:0034198 | cellular response to amino acid starvation | 0.52% (1/193) | 5.56 | 0.020979 | 0.044368 |
| GO:1990928 | response to amino acid starvation | 0.52% (1/193) | 5.56 | 0.020979 | 0.044368 |
| GO:0009889 | regulation of biosynthetic process | 6.22% (12/193) | 0.97 | 0.020668 | 0.044478 |
| GO:0022607 | cellular component assembly | 2.59% (5/193) | 1.69 | 0.020649 | 0.044568 |
| GO:0043687 | post-translational protein modification | 3.11% (6/193) | 1.5 | 0.020612 | 0.044619 |
| GO:0031326 | regulation of cellular biosynthetic process | 6.22% (12/193) | 0.98 | 0.020564 | 0.044647 |
| GO:0006508 | proteolysis | 3.63% (7/193) | 1.36 | 0.020914 | 0.044747 |
| GO:0004536 | DNA nuclease activity | 1.04% (2/193) | 3.15 | 0.021854 | 0.046088 |
| GO:0046033 | AMP metabolic process | 0.52% (1/193) | 5.43 | 0.022864 | 0.047942 |
| GO:0009330 | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex | 0.52% (1/193) | 5.43 | 0.022864 | 0.047942 |
| GO:0008186 | ATP-dependent activity, acting on RNA | 1.04% (2/193) | 3.1 | 0.023316 | 0.048613 |
| GO:0003724 | RNA helicase activity | 1.04% (2/193) | 3.1 | 0.023316 | 0.048613 |
| GO:0070536 | protein K63-linked deubiquitination | 0.52% (1/193) | 5.39 | 0.023491 | 0.048841 |
| GO:0004518 | nuclease activity | 2.07% (4/193) | 1.89 | 0.023914 | 0.049579 |
| GO:0031261 | DNA replication preinitiation complex | 0.52% (1/193) | 5.36 | 0.024119 | 0.049863 |
